Robenacoxib

• Description :

  Robenacoxib is a nonsteroidal anti-inflammatory and analgesic agent. Robenacoxib is a selective COX-2 inhibitor[1][2].

• CAS Number :

  [220991-32-2]

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H361, H412

• Target :

  COX

• Type :

  Reference compound

• Related Pathways :

  Immunology/Inflammation

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/robenacoxib.html

• Purity :

  99.56

• Solubility :

  DMSO : 125 mg/mL (ultrasonic)

• Smiles :

  O=C(CC1=CC(CC)=CC=C1NC2=C(C(F)=CC(F)=C2F)F)O

• Molecular Formula :

  C16H13F4NO2

• Molecular Weight :

  327.27

• Precautions :

  H302, H361, H412

• References & Citations :

  [1]Kongara K, et al. Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy. Vet Med (Auckl) . 2018 Aug 15;9:53-61.|[2]Schmid VB, et al. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. J Vet Pharmacol Ther. 2010 Apr;33 (2) :118-31.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported